Loading...
XJPX
2269
Market cap6.42bUSD
Jul 10, Last price  
3,771.00JPY
1D
-1.90%
1Q
-3.38%
Jan 2017
-58.83%
IPO
128.55%
Name

Meiji Holdings Co Ltd

Chart & Performance

D1W1MN
XJPX:2269 chart
P/E
27.49
P/S
0.82
EPS
137.19
Div Yield, %
2.67%
Shrs. gr., 5y
-1.36%
Rev. gr., 5y
0.87%
Revenues
1.24t
+7.83%
702,750,000,000706,988,000,000711,394,000,0001,106,655,000,0001,111,000,000,0001,109,275,000,0001,126,520,000,0001,148,076,000,0001,161,152,000,0001,223,746,000,0001,242,480,000,0001,240,860,000,0001,254,380,000,0001,252,706,000,0001,191,765,000,0001,013,092,000,0001,062,157,000,0001,105,494,000,0001,154,074,000,0001,244,470,595,000
Net income
37.19b
-26.79%
13,708,000,0009,226,000,0005,933,000,00013,088,000,0009,552,000,0006,805,000,00016,646,000,00019,060,000,00030,891,000,00062,580,000,00060,786,000,00061,278,000,00061,868,000,00067,318,000,00065,655,000,00087,497,000,00069,424,000,00050,675,000,00050,800,000,00037,192,418,000
CFO
59.93b
-13.12%
37,123,000,00018,542,000,00016,991,000,00047,707,000,00057,995,000,00030,597,000,00050,622,000,00063,847,000,00086,487,000,000105,155,000,00081,888,000,000108,775,000,000112,100,000,000114,103,000,000123,683,000,000127,526,000,00085,013,000,000107,983,000,00068,979,000,00059,930,720,000
Dividend
Sep 29, 202655 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Meiji Holdings Co., Ltd., an international enterprise headquartered in Tokyo, Japan, was established in 1916. Through its various subsidiaries, the company specializes in the global manufacturing and distribution of a broad spectrum of products across the food, confectionery, nutritional, and pharmaceutical sectors. Its business activities are distinctly categorized into two core divisions: Food and Pharmaceutical. The Food segment encompasses a wide array of products, including dairy items such as yogurt, cheese, drinking milk, butter, margarine, cream, and ice cream. It also offers various beverages, ready-to-eat meals, and an extensive selection of confectioneries like chocolates, gummy products, and chewing gums. Nutritional offerings within this segment comprise sports nutrition products, infant formula, liquid dietary supplements, and beauty-focused supplements. Additionally, it provides essential ingredients like corn sweeteners and sugar, animal feed, and crucial transportation and distribution services. The Pharmaceutical segment is dedicated to the development and commercialization of medications, including treatments for infectious diseases and central nervous system disorders, alongside a portfolio of generic and over-the-counter (OTC) drugs. This division also serves as a significant provider of human and animal vaccines, blood plasma products, and a range of agricultural and livestock chemicals. For veterinary applications, Meiji offers a comprehensive suite of products for livestock and fisheries, featuring antimicrobial injections, disinfectants, oral medications, insecticides, dewormers, pain relievers, anti-inflammatory agents, hemostatic compounds, and breeding aids. Furthermore, it produces insecticides, metabolites, feed additives, and blended feeds, alongside specialized health solutions for companion animals, such as anesthetics, painkillers, anti-parasitic and gastrointestinal drugs, antibacterial agents, antiplasmin agents, vitamin E preparations, and dietary supplements.
IPO date
Apr 01, 2009
Employees
17,290
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT